Adaptimmune Reports First Quarter 2017 Financial Results
May 10, 2017 11:32 am UTC| Business
– Offerings in March and April raised net proceeds of $103.2 million; operations funded through to late 2019– –Initiated study with wholly-owned AFP SPEAR T-cells– – Initial data from three wholly-owned assets (MAGE-A4,...
Adaptimmune Reports First Quarter 2017 Financial Results
May 10, 2017 11:32 am UTC| Business
– Offerings in March and April raised net proceeds of $103.2 million; operations funded through to late 2019– –Initiated study with wholly-owned AFP SPEAR T-cells– – Initial data from three wholly-owned assets (MAGE-A4,...
May 10, 2017 11:32 am UTC| Business
PHILADELPHIA and OXFORD, U.K., May 10, 2017 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that it has initiated the first site for its AFP SPEAR T-cell study...
May 10, 2017 11:32 am UTC| Business
PHILADELPHIA and OXFORD, U.K., May 10, 2017 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that it has initiated the first site for its AFP SPEAR T-cell study...
May 10, 2017 11:32 am UTC| Business
PHILADELPHIA and OXFORD, U.K., May 10, 2017 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that it has initiated the first site for its AFP SPEAR T-cell study...
Intra-Cellular Therapies Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 10, 2017 11:32 am UTC| Business
NEW YORK, May 10, 2017 -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced its financial...
Intra-Cellular Therapies Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 10, 2017 11:32 am UTC| Business
NEW YORK, May 10, 2017 -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced its financial...